Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational, Single-center Study of Radiotherapy Combined With Immunotherapy for Massive Tumors

NCT04587817 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT04587817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04587817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational, Single-center Study of Radiotherapy Combined With Immunotherapy for Massive Tumors
Lead sponsor
Peking University First Hospital
Phase
Observational
Overall status
Unknown status
Start date
October 15, 2020
Completion date
December 1, 2023
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bulky tumor, immunotherapy, sbrt